India's Deadly Medicine: Quick Fixes Fail

Months after children tragically died from poisonous cough syrups, government measures are being implemented. Cough syrups have been moved from a category allowing village stores to sell them without a prescription to requiring a doctor's order. This change, however, is questioned as a genuine solution to the ongoing contamination crisis.

India has a grim history with contaminated cough syrups, with numerous poisonings linked to the chemical DEG, dating back to 1972. These issues have tragically extended beyond India's borders, with Indian-made syrups implicated in child deaths in Gambia, Cameroon, and Uzbekistan. Experts point to poorly regulated factories and insufficient drug inspections as key contributors.

Further compounding the problem are issues such as the temporary restoration of factory licenses and a lack of robust systems for reporting poisonings or recalling dangerous medicines. Despite existing rules requiring companies to test medicines and track ingredients, these are frequently disregarded, with regulators failing to ensure compliance.

Historical parallels, like the 1937 US tragedy that led to stricter drug laws, highlight the potential for effective regulation. Yet, in India, a pattern of denial and superficial fixes, like the prescription requirement, persists. The critical question remains whether every cough syrup on the market is genuinely safe, a question to which the current answer is a concerning no.